Breaking News

ANJAC Health & Beauty Acquires the CDMO Pillar5Pharma

The deal strengthens both its presence in North America and its pharmaceutical activities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ANJAC Health & Beauty has acquired Pillar5 Pharma, a contract development and manufacturing organization (CDMO) specializing in the production of sterile ophthalmic solutions and niche solid dose manufacturing. The acquisition reinforces ANJAC’s international expansion and broadens its health offerings with new ophthalmic services for local and international brands and laboratories. This is ANJAC’s second major operation of 2022, following its acquisition of Apollo Healthcare in January. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters